Nonalkolik hepatosteatozda portal ven pulsatilite indeksi hepatik arter rezistif indeksi ile karaciğer fibrozisi öngörüsü için bir prediktif parametre olarak kullanılabilir mi?
Author:
DİLEK Okan,KAYA Ömer
Publisher
Acta Medica Alanya
Reference15 articles.
1. Referans 1. Ahmed MH, Byrne CD. Current treatment of non-alcoholic fatty liver disease. Diabetes Obes Metab 2009;11:188-95.
2. Referans 2. Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 2005;16:421-7.
3. Referans 3. Schwimmer JB, Deustch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003;143:500-5.
4. Referans 4. Aube C, Oberti F, Korali N, Namour MA, Loisel D, Tanguy JY, et al. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 1999;30:472-8.
5. Referans 5. Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003;15:539-43.